Tern Therapeutics
Washington
About Tern Therapeutics
Tern Therapeutics develops transformative, one-time genetic treatments for rare diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $15.0M
- Funding stage: Seed
- Last round: Seed (Aug 2024)
- Website: terntx.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/tern-therapeutics-80122 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.